T1	PROC 46 60	Ensayo clínico
#1	AnnotatorNotes T1	C0008976; Clinical Trials; Research Activity
T2	PROC 66 100	evaluar la seguridad y la eficacia
#2	AnnotatorNotes T2	C0511730; Identify product efficacy and safety issues; Health Care Activity
T3	PROC 119 129	prevención
#3	AnnotatorNotes T3	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T4	DISO 136 144	neumonía
#4	AnnotatorNotes T4	C0032285; Pneumonia; Disease or Syndrome
T5	DISO 161 207	infección bacteriana por Staphylococcus aureus
#5	AnnotatorNotes T5	C0859310; Bacterial infection due to staphylococcus aureus; Disease or Syndrome
T6	PROC 259 327	Estudio de fase 2, aleatorizado, doble ciego, controlado con placebo
T7	DISO 708 732	Colonizados por S aureus
T8	PROC 369 403	evaluar la eficacia y la seguridad
#6	AnnotatorNotes T8	C0511730; Identify product efficacy and safety issues; Health Care Activity
T9	CHEM 420 448	anticuerpo monoclonal humano
T10	CHEM 459 495	toxina alfa de Staphylococcus aureus
#7	AnnotatorNotes T10	C0075167; staphylococcal alpha-toxin; Amino Acid, Peptide, or Protein · Biologically Active Substance · Hazardous or Poisonous Substance
T11	PROC 528 548	ventilación mecánica
#8	AnnotatorNotes T11	C0199470; Mechanical ventilation; Therapeutic or Preventive Procedure
T12	DISO 572 606	Neumonía por Staphylococcus aureus
#9	AnnotatorNotes T12	C0857862; Staphylococcus Aureus Pneumonia; Disease or Syndrome
T13	PROC 633 643	Prevención
#10	AnnotatorNotes T13	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T14	DISO 647 681	neumonía por Staphylococcus aureus
#11	AnnotatorNotes T14	C0857862; Staphylococcus Aureus Pneumonia; Disease or Syndrome
T15	PROC 753 763	intubación
#12	AnnotatorNotes T15	C0021925; Intubation (procedure); Therapeutic or Preventive Procedure
T16	PROC 766 786	ventilación mecánica
#13	AnnotatorNotes T16	C0199470; Mechanical ventilation; Therapeutic or Preventive Procedure
T17	DISO 824 832	neumonía
#14	AnnotatorNotes T17	C0032285; Pneumonia; Disease or Syndrome
T18	DISO 867 892	Enfermedad estafilocócica
T19	PROC 913 927	aleatorización
#15	AnnotatorNotes T19	C0034656; Randomization; Research Activity
T20	DISO 929 944	lesión pulmonar
#16	AnnotatorNotes T20	C0273115; Lung Injury; Injury or Poisoning
T21	ANAT 936 944	pulmonar
#17	AnnotatorNotes T21	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T22	DISO 980 988	neumonía
#18	AnnotatorNotes T22	C0032285; Pneumonia; Disease or Syndrome
T23	DISO 990 1009	enfermedad pulmonar
#19	AnnotatorNotes T23	C0024115; Lung diseases; Disease or Syndrome
T24	PROC 1040 1052	traqueotomía
#20	AnnotatorNotes T24	C0040591; Tracheotomy procedure; Therapeutic or Preventive Procedure
T25	DISO 1132 1142	moribundos
#21	AnnotatorNotes T25	C0424547; Moribund (finding); Finding
T26	CHEM 407 415	MEDI4893
#22	AnnotatorNotes T26	C4078046; MEDI4893; Amino Acid, Peptide, or Protein · Immunologic Factor
T27	CHEM 104 112	MEDI4893
#23	AnnotatorNotes T27	C4078046; MEDI4893; Amino Acid, Peptide, or Protein · Immunologic Factor
T28	ANAT 1001 1009	pulmonar
#24	AnnotatorNotes T28	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T29	CHEM 1077 1089	antibióticos
#25	AnnotatorNotes T29	C0003232; Antibiotics; Antibiotic
T30	Date 13 17	2014
T31	LIVB 186 207	Staphylococcus aureus
#26	AnnotatorNotes T31	C0038172; Staphylococcus aureus; Bacterium
T32	LIVB 211 235	pacientes de alto riesgo
#27	AnnotatorNotes T32	C0870646; High Risk Populations; Population Group (?)
T34	Dose 352 363	dosis única
T36	LIVB 474 495	Staphylococcus aureus
#28	AnnotatorNotes T36	C0038172; Staphylococcus aureus; Bacterium
T38	LIVB 500 515	sujetos adultos
#29	AnnotatorNotes T38	C0681850; Study Subject; Group + C0001675; Adult; Age Group
T39	Neg_cue 799 810	sin ninguna
T40	LIVB 878 892	estafilocócica
#30	AnnotatorNotes T40	C0038170; Genus staphylococcus; Bacterium
T41	Date 1010 1016	actual
T42	LIVB 1018 1027	pacientes
#31	AnnotatorNotes T42	C0030705; Patients; Patient or Disabled Group
T43	Duration 1028 1036	crónicos
T44	Date 1054 1065	actualmente
T45	LIVB 1108 1120	estafilococo
#32	AnnotatorNotes T45	C0038170; Genus staphylococcus; Bacterium
T46	LIVB 1122 1131	pacientes
#33	AnnotatorNotes T46	C0030705; Patients; Patient or Disabled Group
T47	LIVB 171 181	bacteriana
#34	AnnotatorNotes T47	C0004611; Bacteria; Bacterium
T48	LIVB 585 606	Staphylococcus aureus
#35	AnnotatorNotes T48	C0038172; Staphylococcus aureus; Bacterium
T49	LIVB 660 681	Staphylococcus aureus
#36	AnnotatorNotes T49	C0038172; Staphylococcus aureus; Bacterium
T33	LIVB 724 732	S aureus
#37	AnnotatorNotes T33	C0038172; Staphylococcus aureus; Bacterium
A1	Population_data T38 Age
A2	Assertion T17 Negated
A3	Status T24 History_of
#38	AnnotatorNotes T6	C0282460; Phase 2 Clinical Trials; Research Activity + C0034656; Randomization; Research Activity + C0013072; Double-Blind Method; Research Activity + C0599724; placebo controlled study; Research Activity · Intellectual Product 
#39	AnnotatorNotes T18	C0038160; Staphylococcal Infections; Disease or Syndrome 
#40	AnnotatorNotes T43	C0205191; chronic; Temporal Concept
#41	AnnotatorNotes T44	C0521116; Current (present time); Temporal Concept 
#42	AnnotatorNotes T41	C0521116; Current (present time); Temporal Concept 
R1	Used_for Arg1:T27 Arg2:T3	
R2	Before Arg1:T27 Arg2:T4	
R3	Causes Arg1:T5 Arg2:T4	
R4	Causes Arg1:T47 Arg2:T5	
R5	Causes Arg1:T31 Arg2:T5	
R8	Experiences Arg1:T32 Arg2:T27	
R9	Has_Dose_or_Strength Arg1:T26 Arg2:T34	
R10	Has_Dose_or_Strength Arg1:T9 Arg2:T34	
R11	Experiences Arg1:T38 Arg2:T26	
R12	Experiences Arg1:T38 Arg2:T11	
R13	Experiences Arg1:T38 Arg2:T9	
R15	Causes Arg1:T48 Arg2:T12	
R16	Causes Arg1:T49 Arg2:T14	
R17	Before Arg1:T13 Arg2:T14	
R18	Causes Arg1:T40 Arg2:T18	
R19	Causes Arg1:T33 Arg2:T7	
T35	Quantifier_or_Qualifier 734 743	se espera
#43	AnnotatorNotes T35	C1517001; Expected (qualifier); Intellectual Product
R22	Has_Quantifier_or_Qualifier Arg1:T15 Arg2:T35	
R23	Has_Quantifier_or_Qualifier Arg1:T16 Arg2:T35	
T37	Quantifier_or_Qualifier 787 797	prolongada
#44	AnnotatorNotes T37	C0439590; Prolonged; Temporal Concept
R24	Has_Quantifier_or_Qualifier Arg1:T16 Arg2:T37	
R25	Has_Quantifier_or_Qualifier Arg1:T15 Arg2:T37	
R26	Negation Arg1:T39 Arg2:T17	
T50	Quantifier_or_Qualifier 833 839	activa
A4	Assertion T50 Negated
#45	AnnotatorNotes T50	C0679217; Active State; Idea or Concept
R27	Has_Quantifier_or_Qualifier Arg1:T17 Arg2:T50	
R28	Negation Arg1:T39 Arg2:T50	
R31	Before Arg1:T15 Arg2:T16	
R32	Overlap Arg1:T7 Arg2:T17	
R33	Overlap Arg1:T18 Arg2:T19	
R34	Location_of Arg1:T21 Arg2:T20	
R35	Causes Arg1:T22 Arg2:T20	
R36	Location_of Arg1:T28 Arg2:T23	
R37	Overlap Arg1:T23 Arg2:T41	
R38	Experiences Arg1:T42 Arg2:T24	
R39	Has_Duration_or_Interval Arg1:T24 Arg2:T43	
R40	Overlap Arg1:T29 Arg2:T44	
T51	Quantifier_or_Qualifier 1101 1120	contra estafilococo
R41	Has_Quantifier_or_Qualifier Arg1:T29 Arg2:T51	
T52	Quantifier_or_Qualifier 1090 1100	sistémicos
#46	AnnotatorNotes T52	C0205373; Systemic; Functional Concept
R42	Has_Quantifier_or_Qualifier Arg1:T29 Arg2:T52	
R43	Experiences Arg1:T46 Arg2:T25	
T53	Quantifier_or_Qualifier 449 495	contra la toxina alfa de Staphylococcus aureus
R44	Has_Quantifier_or_Qualifier Arg1:T9 Arg2:T53	
R6	Before Arg1:T3 Arg2:T4	
R7	Experiences Arg1:T32 Arg2:T3	
R45	Experiences Arg1:T32 Arg2:T4	
R46	Experiences Arg1:T32 Arg2:T5	
A5	Experiencer T42 Patient
A6	Experiencer T46 Patient
A7	Experiencer T32 Patient
A8	Experiencer T38 Patient
A9	Status T15 Future
A10	Status T16 Future
A11	Status T37 Future
